Bioarctic AB Says Health Canada Grants Authorization For Leqembi® (Lecanemab)
ReutersOct 26, 2025 11:38 PM
Oct 26 (Reuters) - BioArctic AB BIOAb.ST:
BIOARCTIC AB -HEALTH CANADA GRANTS AUTHORIZATION FOR LEQEMBI® (LECANEMAB)
Further company coverage: [BIOAb.ST]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Fed’s October Rate Cut: Easing Cycle Continues, Gold Likely to Keep Rising
In an environment of sustained rate cuts, we remain optimistic about gold's performance over the next 12 months.TradingKey
an hour ago
Intel Q3 2025: AI Boost and Partnerships Signal a New Era for US Chip Leadership
TradingKey - Intel’s Q3 FY2025 earnings smashed Wall Street projections, sending the stock up 8% in after-hours trading and fueling renewed confidence in the company’s turnaround story.TradingKey
Fri, Oct 24
Tesla’s Megapack Leads the Surge in Energy Storage Stocks
TradingKey - Long an afterthought in the U.S. energy system, grid-scale battery storage is rapidly moving from the margins to the mainstream.TradingKey
Fri, Oct 24
Thinking of investing in SOL? Here's a deep dive into Solana’s price trends and future outlook
Solana has demonstrated strong technical resilience and ecosystem growth in 2025. If it continues expanding use cases, stabilizing network performance, and navigating regulatory hurdles, SOL could become a core Web3 infrastructure asset. Institutions remain bullish on its long-term potential, especiTradingKey
Fri, Oct 24
